Table of Content

1 Antibody Drug Conjugate Market Overview
1.1 Antibody Drug Conjugate Product Scope
1.2 Antibody Drug Conjugate Segment by Type
1.2.1 Global Antibody Drug Conjugate Sales by Type (2016 & 2021 & 2027)
1.2.2 Adcetris
1.2.3 Kadcyl
1.2.4 Other
1.3 Antibody Drug Conjugate Segment by Application
1.3.1 Global Antibody Drug Conjugate Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Pharmaceutical Company
1.3.4 Research Institutions
1.4 Antibody Drug Conjugate Market Estimates and Forecasts (2016-2027)
1.4.1 Global Antibody Drug Conjugate Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Antibody Drug Conjugate Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Antibody Drug Conjugate Price Trends (2016-2027)

2 Antibody Drug Conjugate Estimates and Forecasts by Region
2.1 Global Antibody Drug Conjugate Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Antibody Drug Conjugate Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Antibody Drug Conjugate Sales Market Share by Region (2016-2021)
2.2.2 Global Antibody Drug Conjugate Revenue Market Share by Region (2016-2021)
2.3 Global Antibody Drug Conjugate Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Antibody Drug Conjugate Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Antibody Drug Conjugate Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Antibody Drug Conjugate Estimates and Projections (2016-2027)
2.4.2 Europe Antibody Drug Conjugate Estimates and Projections (2016-2027)
2.4.3 China Antibody Drug Conjugate Estimates and Projections (2016-2027)
2.4.4 Japan Antibody Drug Conjugate Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Antibody Drug Conjugate Estimates and Projections (2016-2027)
2.4.6 India Antibody Drug Conjugate Estimates and Projections (2016-2027)

3 Global Antibody Drug Conjugate Competition Landscape by Players
3.1 Global Top Antibody Drug Conjugate Players by Sales (2016-2021)
3.2 Global Top Antibody Drug Conjugate Players by Revenue (2016-2021)
3.3 Global Antibody Drug Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody Drug Conjugate as of 2020)
3.4 Global Antibody Drug Conjugate Average Price by Company (2016-2021)
3.5 Manufacturers Antibody Drug Conjugate Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Antibody Drug Conjugate Market Size by Type
4.1 Global Antibody Drug Conjugate Historic Market Review by Type (2016-2021)
4.1.1 Global Antibody Drug Conjugate Sales Market Share by Type (2016-2021)
4.1.2 Global Antibody Drug Conjugate Revenue Market Share by Type (2016-2021)
4.1.3 Global Antibody Drug Conjugate Price by Type (2016-2021)
4.2 Global Antibody Drug Conjugate Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Antibody Drug Conjugate Sales Forecast by Type (2022-2027)
4.2.2 Global Antibody Drug Conjugate Revenue Forecast by Type (2022-2027)
4.2.3 Global Antibody Drug Conjugate Price Forecast by Type (2022-2027)

5 Global Antibody Drug Conjugate Market Size by Application
5.1 Global Antibody Drug Conjugate Historic Market Review by Application (2016-2021)
5.1.1 Global Antibody Drug Conjugate Sales Market Share by Application (2016-2021)
5.1.2 Global Antibody Drug Conjugate Revenue Market Share by Application (2016-2021)
5.1.3 Global Antibody Drug Conjugate Price by Application (2016-2021)
5.2 Global Antibody Drug Conjugate Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Antibody Drug Conjugate Sales Forecast by Application (2022-2027)
5.2.2 Global Antibody Drug Conjugate Revenue Forecast by Application (2022-2027)
5.2.3 Global Antibody Drug Conjugate Price Forecast by Application (2022-2027)

6 North America Antibody Drug Conjugate Market Facts & Figures
6.1 North America Antibody Drug Conjugate Sales by Company
6.1.1 North America Antibody Drug Conjugate Sales by Company (2016-2021)
6.1.2 North America Antibody Drug Conjugate Revenue by Company (2016-2021)
6.2 North America Antibody Drug Conjugate Sales Breakdown by Type
6.2.1 North America Antibody Drug Conjugate Sales Breakdown by Type (2016-2021)
6.2.2 North America Antibody Drug Conjugate Sales Breakdown by Type (2022-2027)
6.3 North America Antibody Drug Conjugate Sales Breakdown by Application
6.3.1 North America Antibody Drug Conjugate Sales Breakdown by Application (2016-2021)
6.3.2 North America Antibody Drug Conjugate Sales Breakdown by Application (2022-2027)

7 Europe Antibody Drug Conjugate Market Facts & Figures
7.1 Europe Antibody Drug Conjugate Sales by Company
7.1.1 Europe Antibody Drug Conjugate Sales by Company (2016-2021)
7.1.2 Europe Antibody Drug Conjugate Revenue by Company (2016-2021)
7.2 Europe Antibody Drug Conjugate Sales Breakdown by Type
7.2.1 Europe Antibody Drug Conjugate Sales Breakdown by Type (2016-2021)
7.2.2 Europe Antibody Drug Conjugate Sales Breakdown by Type (2022-2027)
7.3 Europe Antibody Drug Conjugate Sales Breakdown by Application
7.3.1 Europe 127 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 127 Sales Breakdown by Application (2022-2027)

8 China Antibody Drug Conjugate Market Facts & Figures
8.1 China Antibody Drug Conjugate Sales by Company
8.1.1 China Antibody Drug Conjugate Sales by Company (2016-2021)
8.1.2 China Antibody Drug Conjugate Revenue by Company (2016-2021)
8.2 China Antibody Drug Conjugate Sales Breakdown by Type
8.2.1 China Antibody Drug Conjugate Sales Breakdown by Type (2016-2021)
8.2.2 China Antibody Drug Conjugate Sales Breakdown by Type (2022-2027)
8.3 China Antibody Drug Conjugate Sales Breakdown by Application
8.3.1 China 158 Sales Breakdown by Application (2016-2021)
8.3.2 China 158 Sales Breakdown by Application (2022-2027)

9 Japan Antibody Drug Conjugate Market Facts & Figures
9.1 Japan Antibody Drug Conjugate Sales by Company
9.1.1 Japan Antibody Drug Conjugate Sales by Company (2016-2021)
9.1.2 Japan Antibody Drug Conjugate Revenue by Company (2016-2021)
9.2 Japan Antibody Drug Conjugate Sales Breakdown by Type
9.2.1 Japan Antibody Drug Conjugate Sales Breakdown by Type (2016-2021)
9.2.2 Japan Antibody Drug Conjugate Sales Breakdown by Type (2022-2027)
9.3 Japan Antibody Drug Conjugate Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Antibody Drug Conjugate Market Facts & Figures
10.1 Southeast Asia Antibody Drug Conjugate Sales by Company
10.1.1 Southeast Asia Antibody Drug Conjugate Sales by Company (2016-2021)
10.1.2 Southeast Asia Antibody Drug Conjugate Revenue by Company (2016-2021)
10.2 Southeast Asia Antibody Drug Conjugate Sales Breakdown by Type
10.2.1 Southeast Asia Antibody Drug Conjugate Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Antibody Drug Conjugate Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Antibody Drug Conjugate Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Antibody Drug Conjugate Market Facts & Figures
11.1 India Antibody Drug Conjugate Sales by Company
11.1.1 India Antibody Drug Conjugate Sales by Company (2016-2021)
11.1.2 India Antibody Drug Conjugate Revenue by Company (2016-2021)
11.2 India Antibody Drug Conjugate Sales Breakdown by Type
11.2.1 India Antibody Drug Conjugate Sales Breakdown by Type (2016-2021)
11.2.2 India Antibody Drug Conjugate Sales Breakdown by Type (2022-2027)
11.3 India Antibody Drug Conjugate Sales Breakdown by Application
11.3.1 India Antibody Drug Conjugate Sales Breakdown by Application (2016-2021)
11.3.2 India Antibody Drug Conjugate Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Antibody Drug Conjugate Business
12.1 Seattle Genetics/Takeda
12.1.1 Seattle Genetics/Takeda Corporation Information
12.1.2 Seattle Genetics/Takeda Business Overview
12.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Seattle Genetics/Takeda Antibody Drug Conjugate Products Offered
12.1.5 Seattle Genetics/Takeda Recent Development
12.2 Roche
12.2.1 Roche Corporation Information
12.2.2 Roche Business Overview
12.2.3 Roche Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Roche Antibody Drug Conjugate Products Offered
12.2.5 Roche Recent Development
12.3 ImmunoGen
12.3.1 ImmunoGen Corporation Information
12.3.2 ImmunoGen Business Overview
12.3.3 ImmunoGen Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021)
12.3.4 ImmunoGen Antibody Drug Conjugate Products Offered
12.3.5 ImmunoGen Recent Development
12.4 Immunomedics
12.4.1 Immunomedics Corporation Information
12.4.2 Immunomedics Business Overview
12.4.3 Immunomedics Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Immunomedics Antibody Drug Conjugate Products Offered
12.4.5 Immunomedics Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Business Overview
12.5.3 Pfizer Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer Antibody Drug Conjugate Products Offered
12.5.5 Pfizer Recent Development
12.6 Celldex Therapeutics
12.6.1 Celldex Therapeutics Corporation Information
12.6.2 Celldex Therapeutics Business Overview
12.6.3 Celldex Therapeutics Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Celldex Therapeutics Antibody Drug Conjugate Products Offered
12.6.5 Celldex Therapeutics Recent Development
12.7 Millennium Pharmaceuticals
12.7.1 Millennium Pharmaceuticals Corporation Information
12.7.2 Millennium Pharmaceuticals Business Overview
12.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Millennium Pharmaceuticals Antibody Drug Conjugate Products Offered
12.7.5 Millennium Pharmaceuticals Recent Development
12.8 Bayer HealthCare
12.8.1 Bayer HealthCare Corporation Information
12.8.2 Bayer HealthCare Business Overview
12.8.3 Bayer HealthCare Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bayer HealthCare Antibody Drug Conjugate Products Offered
12.8.5 Bayer HealthCare Recent Development
12.9 Mersana Therapeutics
12.9.1 Mersana Therapeutics Corporation Information
12.9.2 Mersana Therapeutics Business Overview
12.9.3 Mersana Therapeutics Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Mersana Therapeutics Antibody Drug Conjugate Products Offered
12.9.5 Mersana Therapeutics Recent Development
12.10 Heidelberg Pharma
12.10.1 Heidelberg Pharma Corporation Information
12.10.2 Heidelberg Pharma Business Overview
12.10.3 Heidelberg Pharma Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Heidelberg Pharma Antibody Drug Conjugate Products Offered
12.10.5 Heidelberg Pharma Recent Development
12.11 Oxford BioTherapeutics
12.11.1 Oxford BioTherapeutics Corporation Information
12.11.2 Oxford BioTherapeutics Business Overview
12.11.3 Oxford BioTherapeutics Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Oxford BioTherapeutics Antibody Drug Conjugate Products Offered
12.11.5 Oxford BioTherapeutics Recent Development
12.12 Takeda Pharmaceutical Company Limited
12.12.1 Takeda Pharmaceutical Company Limited Corporation Information
12.12.2 Takeda Pharmaceutical Company Limited Business Overview
12.12.3 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Products Offered
12.12.5 Takeda Pharmaceutical Company Limited Recent Development

13 Antibody Drug Conjugate Manufacturing Cost Analysis
13.1 Antibody Drug Conjugate Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antibody Drug Conjugate
13.4 Antibody Drug Conjugate Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antibody Drug Conjugate Distributors List
14.3 Antibody Drug Conjugate Customers

15 Market Dynamics
15.1 Antibody Drug Conjugate Market Trends
15.2 Antibody Drug Conjugate Drivers
15.3 Antibody Drug Conjugate Market Challenges
15.4 Antibody Drug Conjugate Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Antibody Drug Conjugate Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Antibody Drug Conjugate Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Antibody Drug Conjugate Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Antibody Drug Conjugate Sales (K Units) by Region (2016-2021)
Table 5. Global Antibody Drug Conjugate Sales Market Share by Region (2016-2021)
Table 6. Global Antibody Drug Conjugate Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Antibody Drug Conjugate Revenue Share by Region (2016-2021)
Table 8. Global Antibody Drug Conjugate Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Antibody Drug Conjugate Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Antibody Drug Conjugate Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Antibody Drug Conjugate Revenue Share Forecast by Region (2022-2027)
Table 12. Global Antibody Drug Conjugate Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Antibody Drug Conjugate Sales Share by Company (2016-2021)
Table 14. Global Antibody Drug Conjugate Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Antibody Drug Conjugate Revenue Share by Company (2016-2021)
Table 16. Global Antibody Drug Conjugate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Drug Conjugate as of 2020)
Table 17. Global Antibody Drug Conjugate Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Antibody Drug Conjugate Manufacturing Sites and Area Served
Table 19. Manufacturers Antibody Drug Conjugate Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Antibody Drug Conjugate Sales (K Units) by Type (2016-2021)
Table 22. Global Antibody Drug Conjugate Sales Share by Type (2016-2021)
Table 23. Global Antibody Drug Conjugate Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Antibody Drug Conjugate Price (USD/Unit) by Type (2016-2021)
Table 25. Global Antibody Drug Conjugate Sales Share by Type (2022-2027)
Table 26. Global Antibody Drug Conjugate Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Antibody Drug Conjugate Revenue Share by Type (2022-2027)
Table 28. Global Antibody Drug Conjugate Price (USD/Unit) by Type (2022-2027)
Table 29. Global Antibody Drug Conjugate Sales (K Units) by Application (2016-2021)
Table 30. Global Antibody Drug Conjugate Sales Share by Application (2016-2021)
Table 31. Global Antibody Drug Conjugate Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Antibody Drug Conjugate Price (USD/Unit) by Application (2016-2021)
Table 33. Global Antibody Drug Conjugate Sales (K Units) by Application (2022-2027)
Table 34. Global Antibody Drug Conjugate Sales Share by Application (2022-2027)
Table 35. Global Antibody Drug Conjugate Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Antibody Drug Conjugate Revenue Share by Application (2022-2027)
Table 37. Global Antibody Drug Conjugate Price (USD/Unit) by Application (2022-2027)
Table 38. North America Antibody Drug Conjugate Sales (K Units) by Company (2016-2021)
Table 39. North America Antibody Drug Conjugate Sales Market Share by Company (2016-2021)
Table 40. North America Antibody Drug Conjugate Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Antibody Drug Conjugate Revenue Market Share by Company (2016-2021)
Table 42. North America Antibody Drug Conjugate Sales by Type (2016-2021) & (K Units)
Table 43. North America Antibody Drug Conjugate Sales Market Share by Type (2016-2021)
Table 44. North America Antibody Drug Conjugate Sales by Type (2022-2027) & (K Units)
Table 45. North America Antibody Drug Conjugate Sales Market Share by Type (2022-2027)
Table 46. North America Antibody Drug Conjugate Sales by Application (2016-2021) & (K Units)
Table 47. North America Antibody Drug Conjugate Sales Market Share by Application (2016-2021)
Table 48. North America Antibody Drug Conjugate Sales by Application (2022-2027) & (K Units)
Table 49. North America Antibody Drug Conjugate Sales Market Share by Application (2022-2027)
Table 50. Europe Antibody Drug Conjugate Sales (K Units) by Company (2016-2021)
Table 51. Europe Antibody Drug Conjugate Sales Market Share by Company (2016-2021)
Table 52. Europe Antibody Drug Conjugate Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Antibody Drug Conjugate Revenue Market Share by Company (2016-2021)
Table 54. Europe Antibody Drug Conjugate Sales by Type (2016-2021) & (K Units)
Table 55. Europe Antibody Drug Conjugate Sales Market Share by Type (2016-2021)
Table 56. Europe Antibody Drug Conjugate Sales by Type (2022-2027) & (K Units)
Table 57. Europe Antibody Drug Conjugate Sales Market Share by Type (2022-2027)
Table 58. Europe Antibody Drug Conjugate Sales by Application (2016-2021) & (K Units)
Table 59. Europe Antibody Drug Conjugate Sales Market Share by Application (2016-2021)
Table 60. Europe Antibody Drug Conjugate Sales by Application (2022-2027) & (K Units)
Table 61. Europe Antibody Drug Conjugate Sales Market Share by Application (2022-2027)
Table 62. China Antibody Drug Conjugate Sales (K Units) by Company (2016-2021)
Table 63. China Antibody Drug Conjugate Sales Market Share by Company (2016-2021)
Table 64. China Antibody Drug Conjugate Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Antibody Drug Conjugate Revenue Market Share by Company (2016-2021)
Table 66. China Antibody Drug Conjugate Sales by Type (2016-2021) & (K Units)
Table 67. China Antibody Drug Conjugate Sales Market Share by Type (2016-2021)
Table 68. China Antibody Drug Conjugate Sales by Type (2022-2027) & (K Units)
Table 69. China Antibody Drug Conjugate Sales Market Share by Type (2022-2027)
Table 70. China Antibody Drug Conjugate Sales by Application (2016-2021) & (K Units)
Table 71. China Antibody Drug Conjugate Sales Market Share by Application (2016-2021)
Table 72. China Antibody Drug Conjugate Sales by Application (2022-2027) & (K Units)
Table 73. China Antibody Drug Conjugate Sales Market Share by Application (2022-2027)
Table 74. Japan Antibody Drug Conjugate Sales (K Units) by Company (2016-2021)
Table 75. Japan Antibody Drug Conjugate Sales Market Share by Company (2016-2021)
Table 76. Japan Antibody Drug Conjugate Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Antibody Drug Conjugate Revenue Market Share by Company (2016-2021)
Table 78. Japan Antibody Drug Conjugate Sales by Type (2016-2021) & (K Units)
Table 79. Japan Antibody Drug Conjugate Sales Market Share by Type (2016-2021)
Table 80. Japan Antibody Drug Conjugate Sales by Type (2022-2027) & (K Units)
Table 81. Japan Antibody Drug Conjugate Sales Market Share by Type (2022-2027)
Table 82. Japan Antibody Drug Conjugate Sales by Application (2016-2021) & (K Units)
Table 83. Japan Antibody Drug Conjugate Sales Market Share by Application (2016-2021)
Table 84. Japan Antibody Drug Conjugate Sales by Application (2022-2027) & (K Units)
Table 85. Japan Antibody Drug Conjugate Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Antibody Drug Conjugate Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Antibody Drug Conjugate Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Antibody Drug Conjugate Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Antibody Drug Conjugate Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Antibody Drug Conjugate Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Antibody Drug Conjugate Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Antibody Drug Conjugate Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Antibody Drug Conjugate Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Antibody Drug Conjugate Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Antibody Drug Conjugate Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Antibody Drug Conjugate Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Antibody Drug Conjugate Sales Market Share by Application (2022-2027)
Table 98. India Antibody Drug Conjugate Sales (K Units) by Company (2016-2021)
Table 99. India Antibody Drug Conjugate Sales Market Share by Company (2016-2021)
Table 100. India Antibody Drug Conjugate Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Antibody Drug Conjugate Revenue Market Share by Company (2016-2021)
Table 102. India Antibody Drug Conjugate Sales by Type (2016-2021) & (K Units)
Table 103. India Antibody Drug Conjugate Sales Market Share by Type (2016-2021)
Table 104. India Antibody Drug Conjugate Sales by Type (2022-2027) & (K Units)
Table 105. India Antibody Drug Conjugate Sales Market Share by Type (2022-2027)
Table 106. India Antibody Drug Conjugate Sales by Application (2016-2021) & (K Units)
Table 107. India Antibody Drug Conjugate Sales Market Share by Application (2016-2021)
Table 108. India Antibody Drug Conjugate Sales by Application (2022-2027) & (K Units)
Table 109. India Antibody Drug Conjugate Sales Market Share by Application (2022-2027)
Table 110. Seattle Genetics/Takeda Corporation Information
Table 111. Seattle Genetics/Takeda Description and Business Overview
Table 112. Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Seattle Genetics/Takeda Antibody Drug Conjugate Product
Table 114. Seattle Genetics/Takeda Recent Development
Table 115. Roche Corporation Information
Table 116. Roche Description and Business Overview
Table 117. Roche Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Roche Antibody Drug Conjugate Product
Table 119. Roche Recent Development
Table 120. ImmunoGen Corporation Information
Table 121. ImmunoGen Description and Business Overview
Table 122. ImmunoGen Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. ImmunoGen Antibody Drug Conjugate Product
Table 124. ImmunoGen Recent Development
Table 125. Immunomedics Corporation Information
Table 126. Immunomedics Description and Business Overview
Table 127. Immunomedics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Immunomedics Antibody Drug Conjugate Product
Table 129. Immunomedics Recent Development
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Pfizer Antibody Drug Conjugate Product
Table 134. Pfizer Recent Development
Table 135. Celldex Therapeutics Corporation Information
Table 136. Celldex Therapeutics Description and Business Overview
Table 137. Celldex Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Celldex Therapeutics Antibody Drug Conjugate Product
Table 139. Celldex Therapeutics Recent Development
Table 140. Millennium Pharmaceuticals Corporation Information
Table 141. Millennium Pharmaceuticals Description and Business Overview
Table 142. Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Millennium Pharmaceuticals Antibody Drug Conjugate Product
Table 144. Millennium Pharmaceuticals Recent Development
Table 145. Bayer HealthCare Corporation Information
Table 146. Bayer HealthCare Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Bayer HealthCare Description and Business Overview
Table 148. Bayer HealthCare Antibody Drug Conjugate Product
Table 149. Bayer HealthCare Recent Development
Table 150. Mersana Therapeutics Corporation Information
Table 151. Mersana Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Mersana Therapeutics Description and Business Overview
Table 153. Mersana Therapeutics Antibody Drug Conjugate Product
Table 154. Mersana Therapeutics Recent Development
Table 155. Heidelberg Pharma Corporation Information
Table 156. Heidelberg Pharma Description and Business Overview
Table 157. Heidelberg Pharma Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Heidelberg Pharma Antibody Drug Conjugate Product
Table 159. Heidelberg Pharma Recent Development
Table 160. Oxford BioTherapeutics Corporation Information
Table 161. Oxford BioTherapeutics Description and Business Overview
Table 162. Oxford BioTherapeutics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Oxford BioTherapeutics Antibody Drug Conjugate Product
Table 164. Oxford BioTherapeutics Recent Development
Table 165. Takeda Pharmaceutical Company Limited Corporation Information
Table 166. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 167. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product
Table 169. Takeda Pharmaceutical Company Limited Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Antibody Drug Conjugate Distributors List
Table 173. Antibody Drug Conjugate Customers List
Table 174. Antibody Drug Conjugate Market Trends
Table 175. Antibody Drug Conjugate Market Drivers
Table 176. Antibody Drug Conjugate Market Challenges
Table 177. Antibody Drug Conjugate Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody Drug Conjugate Product Picture
Figure 2. Global Antibody Drug Conjugate Sales Market Share by Type in 2021 & 2027
Figure 3. Adcetris Product Picture
Figure 4. Kadcyl Product Picture
Figure 5. Other Product Picture
Figure 6. Global Antibody Drug Conjugate Sales Market Share by Application in 2021 & 2027
Figure 7. Hospital Examples
Figure 8. Pharmaceutical Company Examples
Figure 9. Research Institutions Examples
Figure 10. Global Antibody Drug Conjugate Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Antibody Drug Conjugate Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Antibody Drug Conjugate Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Antibody Drug Conjugate Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 14. Global Antibody Drug Conjugate Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Antibody Drug Conjugate Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Antibody Drug Conjugate Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Antibody Drug Conjugate Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Antibody Drug Conjugate Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Antibody Drug Conjugate Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Antibody Drug Conjugate Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Antibody Drug Conjugate Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Antibody Drug Conjugate Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Antibody Drug Conjugate Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Antibody Drug Conjugate Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Antibody Drug Conjugate Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Antibody Drug Conjugate Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Antibody Drug Conjugate Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Antibody Drug Conjugate Players Market Share by Revenue in Antibody Drug Conjugate: 2016 & 2020
Figure 29. Antibody Drug Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Antibody Drug Conjugate Revenue Share by Type (2016-2021)
Figure 31. Global Antibody Drug Conjugate Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Antibody Drug Conjugate Revenue Share by Application (2016-2021)
Figure 33. Global Antibody Drug Conjugate Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Antibody Drug Conjugate Sales Market Share by Type in 2020
Figure 35. North America Antibody Drug Conjugate Sales Market Share by Application in 2020
Figure 36. Europe Antibody Drug Conjugate Sales Market Share by Type in 2020
Figure 37. Europe Antibody Drug Conjugate Sales Market Share by Application in 2020
Figure 38. China Antibody Drug Conjugate Sales Market Share by Type in 2020
Figure 39. China Antibody Drug Conjugate Sales Market Share by Application in 2020
Figure 40. Japan Antibody Drug Conjugate Sales Market Share by Type in 2020
Figure 41. Japan Antibody Drug Conjugate Sales Market Share by Application in 2020
Figure 42. Southeast Asia Antibody Drug Conjugate Sales Market Share by Type in 2020
Figure 43. Southeast Asia Antibody Drug Conjugate Sales Market Share by Application in 2020
Figure 44. India Antibody Drug Conjugate Sales Market Share by Type in 2020
Figure 45. India Antibody Drug Conjugate Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Antibody Drug Conjugate
Figure 48. Manufacturing Process Analysis of Antibody Drug Conjugate
Figure 49. Antibody Drug Conjugate Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed